Company intelligence / Profile preview

Kapadi

Ownership: Private
Development stage: Other

Overview

Kapadi is a leading global oncology-focused contract research organization specializing in complex clinical trials for biopharmaceutical companies. It offers comprehensive solutions for immuno-oncology assets, cell and gene therapies, rare diseases, hematology, immunology, and vaccines. The company leverages an extensive network of specialty sites across North America and Europe to accelerate innovative research in both common and rare indications. Its expertise spans planning through post-marketing initiatives with regulatory experience worldwide.

Therapeutic areas: OncologyRare DiseasesImmunologyHematology
Modalities: BiologicCell therapyGene therapySmall moleculeVaccine
Industry: Contract Research Organization

Partnerships

Works with biopharmaceutical companies globally as clients/partners

Beyond the preview

Go deeper on Kapadi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kapadi.

Explore the full profile